Caryl E. Sortwell, Ph.D.

Translational Science & Molecular Medicine Michigan State University, East Lansing, MI 
Parkinson's disease therapeutics
"Caryl Sortwell"
Mean distance: 16.69 (cluster 19)
Cross-listing: Neuropathology Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gezer AO, Kochmanski J, VanOeveren SE, et al. (2020) Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits. Neurobiology of Disease. 104947
Steece-Collier K, Collier TJ, Lipton JW, et al. (2020) Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in fisher 344 vs. Lewis hemiparkinsonian rats. Experimental Neurology. 113327
Sellnow RC, Steece-Collier K, Altwal F, et al. (2020) Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Patterson JR, Duffy MF, Kemp CJ, et al. (2019) Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils. Neurobiology of Disease. 104525
Collier TJ, Sortwell CE, Mercado NM, et al. (2019) Cell therapy for Parkinson's disease: Why it doesn't work every time. Movement Disorders : Official Journal of the Movement Disorder Society
Patterson JR, Polinski NK, Duffy MF, et al. (2019) Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo. Journal of Visualized Experiments : Jove
Steece-Collier K, Stancati JA, Collier NJ, et al. (2019) Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society
Fischer DL, Sortwell CE. (2018) BDNF provides many routes toward STN DBS-mediated disease modification. Movement Disorders : Official Journal of the Movement Disorder Society
Duffy MF, Collier TJ, Patterson JR, et al. (2018) Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson's Disease. Frontiers in Neuroscience. 12: 621
Raghunathan R, Polinski NK, Klein JA, et al. (2018) Glycomic and Proteomic changes in aging brain nigrostriatal pathway. Molecular & Cellular Proteomics : McP
See more...